Skip to content
OpenCapital
Get started

SION SION Free cash flow

Free cash flow at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.29B+66.4%
AbbVie logo
AbbVieABBV
$3.56B+155%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$26.47M-11.5%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$62.19M-125%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-$133.67M+2.1%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
——

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%

Valuation

See full
Market cap$1.8B—
Enterprise value$1.74B—

Returns & leverage

See full
Return on equity-26.7%—
Debt / equity0×0.0×
Current ratio22.6×-6.1×

Where this comes from

Calculated from SION’s reported figures.

−$21.8Mnet cash from operating−-capital expenditures=-$21.84M

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's free cash flow?
SION (SION) reported free cash flow of -$21.84M in Q1 2026.
How has SION's free cash flow changed year-over-year?
SION's free cash flow decreased by 33.4% year-over-year, from -$16.37M to -$21.84M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.